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Abstract
[PSI
+], the prion form of the yeast Sup35 protein, results from the structural conversion of Sup35 from a soluble form into an
infectious amyloid form. The infectivity of prions is thought to result from chaperone-dependent fiber cleavage that breaks
large prion fibers into smaller, inheritable propagons. Like the mammalian prion protein PrP, Sup35 contains an
oligopeptide repeat domain. Deletion analysis indicates that the oligopeptide repeat domain is critical for [PSI
+]
propagation, while a distinct region of the prion domain is responsible for prion nucleation. The PrP oligopeptide repeat
domain can substitute for the Sup35 oligopeptide repeat domain in supporting [PSI
+] propagation, suggesting a common
role for repeats in supporting prion maintenance. However, randomizing the order of the amino acids in the Sup35 prion
domain does not block prion formation or propagation, suggesting that amino acid composition is the primary determinant
of Sup35’s prion propensity. Thus, it is unclear what role the oligopeptide repeats play in [PSI
+] propagation: the repeats
could simply act as a non-specific spacer separating the prion nucleation domain from the rest of the protein; the repeats
could contain specific compositional elements that promote prion propagation; or the repeats, while not essential for prion
propagation, might explain some unique features of [PSI
+]. Here, we test these three hypotheses and show that the ability of
the Sup35 and PrP repeats to support [PSI
+] propagation stems from their amino acid composition, not their primary
sequences. Furthermore, we demonstrate that compositional requirements for the repeat domain are distinct from those of
the nucleation domain, indicating that prion nucleation and propagation are driven by distinct compositional features.
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Introduction
The [PSI
+] prion of Saccharomyces cerevisiae results from the
structural conversion of the Sup35 protein into an infectious
amyloid conformation [1,2,3]. Because of the rapid growth rate
and ease of genetic manipulation of yeast, [PSI
+] has provided a
useful model system for examining the mechanism of prion
formation and propagation. Sup35 is an essential component of
the translation termination machinery in yeast [4,5]. Sup35 is
composed of three functionally and structurally distinct domains
(Figure 1): the C-terminal domain (a.a. 254–685) is essential for the
translation termination activity, the prion-forming domain (PFD;
a.a. 1–114) drives the structural conversion to amyloid, and the
highly charged middle domain has no known function other than
its ability to stabilize [PSI
+] fibers [6,7,8,9].
The Sup35 PFD is composed of two separate sub-domains
thought to have distinct functions (Figure 1A). The glutamine/
asparagine-rich (Q/N-rich) tract (amino acids 1–39) is primarily
responsible for prion nucleation and fiber growth, while the
remained of the PFD (amino acids 40–114) is thought to be
primarily involved in prion propagation [8,10,11,12,13]; this
region dominated by an oligopeptide repeat domain (ORD)
spanning amino acids 40–96. The functional delineation between
these two sub-domains is not absolute; for example, tyrosine
residues in the ORD have recently been implicated in prion
nucleation [14]. Nevertheless, a large body of evidence supports an
essential role for the ORD in prion propagation.
The ORD consists of 5K degenerate repeats of the consensus
sequence (
P/Q)QGGYQ(
Q/S)YN ([10,11]; Figure 1B). Truncation
of all or part of the ORD [7,10,11,12], or replacement of the
repeats with a random sequence [15], destabilizes or eliminates
[PSI
+]. In yeast, the chaperone protein Hsp104 is essential for
[PSI
+] propagation [16]. Prion aggregates that are too large are
not efficiently segregated into daughter cells, resulting in prion loss
[17]. Hsp104 cleaves prion fibers, generating new smaller prion
‘‘seeds’’ that can be distributed to daughter cells upon cell division
[18,19,20]. Because deletion of one or more repeats increases the
average [PSI
+] aggregate size, it has been suggested that the
repeats facilitate Hsp104-dependent fragmentation, either by
acting as a direct binding site for Hsp104 or by changing the
conformation of the amyloid core to allow for Hsp104 access [13].
Replacement of the Sup35 ORD in S. cerevisiae with the
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previously been shown to be a potent [PSI
+] forming protein [21],
significantly affects prion propagation and allows for prion
maintenance in the absence of Hsp104 [15]. Chimeric proteins
in which the PFD of Sup35 has been replaced with a poly Q tract
(Q62) can form amyloids, but these amyloids are not stably
propagated; however, addition of the ORD from Sup35 allows for
stable propagation [10]. Therefore, it has been proposed that
efficient chaperone-dependent aggregate cleavage may represent
the difference between infectious and non-infectious amyloids, and
that repeat sequences may play a critical role in allowing for
chaperone-dependent cleavage [10].
Although numerous studies have demonstrated that the region
encompassing the ORD is important for maintenance of wild-type
[PSI
+], none of these studies has examined whether repeats per se
are required for this function, or whether some other feature of the
ORD allows for prion maintenance. Ure2, a highly studied yeast
protein responsible for the [URE3] prion, does not contain
repeats, demonstrating that repeats are not a necessary feature for
prion maintenance. Additionally, four of five scrambled mutants of
Sup35 wherein the primary sequence of the PFD was randomized
while maintaining amino acid composition were able to stably
maintain [PSI
+], suggesting that composition, not primary
sequence is the major determinant of the [PSI
+] phenotype [22].
However, these scrambling results have not diminished the
attention focused on the ORD. One reason for this continued
attention is that similar repeats are found in the mammalian prion
protein PrP. The PrP ORD consists of five repeats with a
consensus sequence of PHGGGWGQ. Therefore, although PrP
and Sup35 are completely unrelated, they both contain repeats
that are rich, to varying degrees, in proline, glycine and glutamine
(Table 1). The prevalence of proline and glycine are particularly
notable, as these residues have low b-sheet and prion propensity
[23,24]. Additionally, the repeats are similar in length (eight versus
nine amino acids for PrP and Sup35, respectively) and in number
(five versus five and a half copies, respectively).
Expansion of the PrP oligopeptide repeat domain is associated
with dominant inherited prion diseases [25,26], while PrP devoid
of the ORD has increased incubation periods and reduced prion
titers in terminally ill mice [27]. Due to the similarities of the
Sup35 and PrP oligopeptide repeats, Sup35 has been used as a
model for examining the role of the PrP repeats in prion formation
and propagation [12,28,29,30]. Oligopeptide repeats from PrP
can functionally replace the Sup35 ORD in supporting [PSI
+]
maintenance [12], and increasing the number of PrP repeats
inserted in place of the Sup35 ORD shortens the lag time for in
vitro fiber formation assays [30].
Given the similarity between the Sup35 and PrP ORDs, it
seems reasonable that the primary sequence of the repeats could
be similarly important for some aspects of [PSI
+] formation or
propagation. Repeat elements are also found in other yeast prion
domains, including those of Rnq1, Mca1 and New1 [10,31,32].
Furthermore, a primary sequence element was recently identified
within another prion protein, Rnq1, that is required for interaction
with the chaperone Sis1p [33,34]; although this element is not
within the repeat domain of Rnq1, it nonetheless bolsters the idea
that primary sequence elements can affect chaperone interactions.
There are three general hypotheses that could reconcile the
sensitivity of the ORD to deletion with the insensitivity of Sup35 to
scrambling. First, the repeats could simply act as a relatively non-
specific spacer, separating the nucleation domain from the highly
charged M domain. Second, the ORD could be important for its
composition, not its primary sequence. Third, Shkundina et al.
proposed that the repeats are not necessary in the context of
artificial prions such as those formed by scrambled Sup35, but that
the repeats may serve a specific function within the context of
naturally occurring [PSI
+] [13]. A related theory is that the repeats
could explain some unique features of [PSI
+]. [PSI
+] is more
sensitive to Hsp104 levels than [URE3]; although both [URE3]
and [PSI
+] are efficiently eliminated by Hsp104 deletion, only
[PSI
+] is eliminated by Hsp104 over-expression [35]. Additionally,
many spontaneous [URE3] isolates are unstable [36], which could
be due to the lack of repeats [10].
To distinguish among these hypotheses, we have made a broad
range of mutant Sup35 proteins in which the ORD was altered.
We found that the primary sequence of the oligopeptide repeats is
nonessential for Hsp104-dependent [PSI
+] maintenance, disprov-
ing the widely held hypothesis that the oligopeptide repeats
provide a specific recognition sequence for chaperone-mediated
fiber cleavage. However, the unique composition of the ORD
relative to the nucleation domain proved critical for its function.
Results
Replacing the ORD with segments from scrambled Sup35
mutant proteins
Because four of five scrambled versions of Sup35 were able to
efficiently propagate prions, we hypothesized that each of these
proteins must have propagation domains analogous to the ORD.
By identifying these regions, we hoped to identify the common
features that allow for Hsp104-dependent prion maintenance.
Therefore, we replaced the 75 amino acid maintenance domain
(a.a. 40–114) of wild-type Sup35, which includes the entire ORD,
with either the first 75 amino acids after the start codon (amino
acids 2–76) or the last 75 amino acids (amino acids 40–114) of the
PFDs from the scrambled Sup35 mutants (Sup35-21, -24, -25, -26
and -27) [22]. The fusion constructs were named FP21N (fusion
protein Sup35-21 N-terminus, indicating that the ORD of wild-
type Sup35 was replaced with the N-terminal 75 amino acids from
the scrambled prion protein Sup35-21), FP21C, FP24N, FP24C,
FP26N, FP26C, FP27N and FP27C (complete sequences can be
found in the supplemental information – see Text S1). Each was
Figure 1. Sup35 layout. (A) Schematic of Sup35. The PFD, the highly
charged middle domain (M-domain) and the C-terminal translation
termination domain (C-domain) are shown. The PFD is enlarged below,
showing the Q/N rich nucleation domain and the oligopeptide repeat
domain (ORD). (B) The Sup35 PFD sequence.
doi:10.1371/journal.pone.0021953.g001
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SUP35 promoter.
Each fusion construct was tested in a S. cerevisiae strain lacking
chromosomal SUP35 and expressing wild-type SUP35 from a
URA3 plasmid. Using plasmid shuffling, each construct was
introduced into a [PSI
+] strain in the place of the endogenous
SUP35. Each strain was then assayed for [PSI
+] propagation by
monitoring nonsense suppression of the ade2-1 allele [37]. In the
absence of [PSI
+], ade2-1 mutants are unable to grow without
adenine and form red colonies in the presence of limiting adenine
due to accumulation of a pigment derived from the substrate of
Ade2p. [PSI
+] causes stop-codon read-through, allowing for
growth without adenine and white or pink colony formation in
the presence of limiting adenine.
Surprisingly, only one of the eight fusion mutants, FP-24N,
appeared completely unable to propagate the Ade
+ phenotype.
When FP-24N was introduced into a wild-type [PSI
+] strain in the
place of the endogenous SUP35, the vast majority of the colonies
were red on limiting adenine, indicating a loss of [PSI
+]
(Figure 2A). Although rare pink colonies were observed, when
these were restreaked onto limiting adenine, the majority of the
resulting colonies were red (data not shown), demonstrating an
inability to maintain the [PSI
+] phenotype.
By contrast, FP-21N showed 100% white colonies (Figure 2A).
To confirm that maintenance of the Ade
+ phenotype was a result
of [PSI
+] maintenance, we tested whether the Ade
+ phenotype
could be cured by treatment with low concentrations of guanidine
HCl. Guanidine HCl cures [PSI
+] [38] by inhibiting Hsp104
[39,40,41]. In all cases, the Ade
+ phenotype was efficiently cured
by treatment with 4 mM guanidine HCl, demonstrating that FP-
21N was indeed maintaining [PSI
+] in an Hsp104-dependent
manner (Figure 2B).
The remaining six constructs showed a mixture of red and white
colonies. In all cases, the white colonies reverted to the red
phenotype upon treatment with guanidine HCl, indicating that the
phenotype was the result of a prion (Figure 2B). There are two
possible explanations for the observed mixture of red and white
colonies. First, the mutants might not efficiently add onto the pre-
existing wild-type [PSI
+] aggregates due to their sequence
differences with wild-type Sup35. This molecular incompatibility
is analogous to the species barrier seen for the mammalian prion
proteins, in which prion transmission is inefficient between
different species due to primary sequence differences between
the proteins. Second, the mutants might have some defect in prion
propagation resulting in prion loss; for example, the mutants might
not be efficiently recognized by cellular chaperones involved in
prion propagation.
To distinguish between these two possibilities, for each of the six
mutants that showed a mixture of red and white colonies, white
colonies were re-streaked to test for stability of the Ade
+
phenotype. In each case, no detectable prion loss was observed
even upon multiple passages on non-selective medium (data not
shown). Sup35 was sequenced from these cells to ensure that prion
propagation was not a result of recombination during plasmid
shuffling between the plasmids expressing wild-type and mutant
Sup35; in all cases colonies were identified which stably
maintained [PSI
+] while expressing only the mutant Sup35 (data
not shown). This demonstrates that the mutants can efficiently
propagate prions and suggests that the red colonies observed in
Figure 2A were due to molecular incompatibility.
Since prion formation occurs by a spontaneous molecular
conversion event, increasing the number of molecules increases the
likelihood of prion formation. To further examine this molecular
incompatibility, we tested the ability of each mutant to form Ade
+
colonies upon transient overexpression of either its matching PFD
domain or the wild-type PFD domain (Figure 2C). For all mutants
tested, Ade
+ colony formation was detectable, and increased with
overexpression. Overexpression of the wild-type PFD domain and
the FP21N PFD domain induced prion formation by full-length
FP21N with comparable efficiencies (Figure 2C), consistent with
the lack of a molecular incompatibility barrier in the plasmid
shuffling assays (Figure 2A). By contrast, all other mutants except
FP24N were induced significantly less efficiently by the wild-type
NM domain than by the matching domain. Additionally, for all
mutants except FP24N, the Ade
+ phenotype in majority of the
Ade
+ colonies was curable by guanidine HCl, but was stably
maintained in the absence of guanidine HCl, confirming that the
Ade
+ phenotype was the result of [PSI
+] formation (data not
shown).
FP24N was induced with roughly comparable efficiencies by the
wild-type and FP24N NM domains. In both cases, the majority
(80–90%) of the Ade
+ colonies were unstable, showing rapid
conversion to an Ade
2 phenotype. The rare stable Ade
+ colonies
were consistently curable by guanidine HCl. Thus, even FP24N,
which was completely unable to propagate wild-type [PSI
+], was
able to form rare stable prions de novo.
Therefore, despite their divergent compositions (Table 2) seven
of the eight mutants tested were able to efficiently propagate wild-
type [PSI
+], although all but one first had to overcome some
degree of molecular incompatibility. Only FP24N showed a
significant prion propagation defect, and even this mutant was
able to rarely form stable, self-propagating prions. These results
demonstrate the broad sequence requirements for the ORD
region.
Table 1. Amino acid compositions of Sup35 and PrP fragments.
Fragment
a Ala Arg Asn Asp Cys Gln Glu Gly His Ile Leu Lys Met Phe Pro Ser Thr Trp Tyr Val Polar
b
Sup35(1–114) 4.4 1.8 17.5 1.8 0.0 28.1 0.0 16.7 0.0 0.0 0.9 0.9 0.9 1.8 4.4 3.5 0.0 0.0 17.5 0.0 49.1
Sup35(1–39) 7.5 2.5 22.5 2.5 0.0 32.5 0.0 10.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 7.5 0.0 0.0 12.5 0.0 62.5
Sup35(40–114) 2.7 1.3 14.7 1.3 0.0 26.7 0.0 20.0 0.0 0.0 1.3 1.3 0.0 2.7 6.7 1.3 0.0 0.0 20.0 0.0 42.7
Sup35(65–104) 2.5 2.5 12.5 2.5 0.0 27.5 0.0 20.0 0.0 0.0 0.0 2.5 0.0 5.0 10.0 0.0 0.0 0.0 15.0 0.0 40.0
Human PrP ORD 0.0 0.0 0.0 0.0 0.0 14.6 0.0 51.2 9.8 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 12.2 0.0 0.0 24.4
aAmino acids 1–114 of Sup35 encompass the entire PFD. Amino acids 1–39 are the nucleation domain, while amino acids 40–114 include the entire ORD. Amino acids
65–104 include the last 3K repeats of the ORD.
bPolar amino acids are Asn, Gln, His, Ser, and Thr.
doi:10.1371/journal.pone.0021953.t001
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Although deletion of even one repeat inhibits efficient prion
propagation, only the first two repeats are required for efficient
addition to existing prion aggregates in vivo [10,12,13]. To
separately examine the primary sequence requirements of the
ORD region for [PSI
+] propagation and molecular compatibility,
we randomized the order of the amino acids in either all of the
repeats or just the last 3K repeats while keeping amino acid
composition constant. In both cases, three scrambled constructs
were generated (see supplemental information for sequences).
All three of the mutants in which the last 3K repeats were
scrambled (ScrKORD1, 2 and 3) showed no molecular
incompatibility with wild-type [PSI
+] aggregates and efficiently
maintained [PSI
+] without any detectable prion loss (Figure 3A
and data not shown). This demonstrates that the primary sequence
of the last 3K repeats plays little or no role in molecular
compatibility or efficiency of prion propagation. By contrast,
scrambling all 5K repeats resulted in significant molecular
incompatibility between the scrambled mutants and wild-type
[PSI
+] aggregates. Of the three constructs in which all 5K repeats
were scrambled (ScrORD1, 2 and 3), only one mutant, ScrORD-
1, overcame this molecular incompatibility at a detectable
frequency (Figure 3A). For ScrORD-1, overcoming this barrier
was a rare event; however, once overcome, maintenance of the
mutant prion was indistinguishable from wild type [PSI
+]
propagation (data not shown). Although the ScrORD-2 and
ScrORD-3 mutant proteins were completely incompatible with
wild-type [PSI
+] aggregates, they could be induced to form stable,
curable prions (Figure 3B and 3C), demonstrating that their failure
to propagate wild type [PSI
+] was a result of molecular
incompatibility, not an intrinsic inability to propagate prions.
Thus, the primary sequence of the first two repeats is an
important determinant of molecular compatibility, consistent with
results from in vitro experiments indicating that the first two
repeats are involved in critical contacts within the core of Sup35
amyloid fibers [42]. However, once this incompatibility barrier is
overcome, the repeats per se are not required for [PSI
+]
maintenance.
Hsp104 over-expression cures scrambled prions
Although repeats are clearly not an absolute requirement for
prion formation and propagation, the presence of repeats in Sup35
could exert a more subtle effect; for example, because of the repeat
region’s role in Hsp104-dependent prion propagation, the repeats
could explain why, unlike [URE3], [PSI
+] is cured by Hsp104
overexpression. Consistent with a subtle role of repeat elements in
prion formation or propagation, scrambled versions of Sup35
show broadly varying rates of prion formation, strengths of the
prion phenotype and efficiencies of prion maintenance [22].
To determine whether the primary sequence of the ORD is
responsible for the unique sensitivity of [PSI
+] to Hsp104
overexpression, we tested the effects of Hsp104 overexpression
Figure 2. Fusion proteins maintain wild type [PSI
+]. (A) Molecular compatibility between wild-type [PSI
+] aggregates and fusion proteins in
which the ORD was replaced with fragments from the scrambled PFDs. Fusion proteins were introduced into a wild-type [PSI
+] strain by plasmid
shuffling and then plated for single colonies on YPD to test for [PSI
+] by color phenotype. Approximate percentages of [PSI
+] cells for each strain are
indicated in parentheses. (B) [PSI
+] stability and curing. White colonies expressing the fusion proteins were streaked for single colonies on YPAD or
YPAD plus 4 mM guandine HCl and then spotted onto YPD to test for [PSI
+]. Because FP-24N did not form any white colonies, guandine HCl
treatment of a red colony is shown. (C) Strains expressing the fusion proteins were transformed with either the empty vector pKT24 (2) or with a
derivative pKT24 expressing from the GAL1 promoter either the NM domain of the same variant of SUP35 (+) or the NM domain of wild-type Sup35
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+] cells expressing Sup35 mutants
in which either the entire PFD [22] or the ORD was scrambled
were transformed with a plasmid that constitutively over-expresses
HSP104 from an ADH1 promoter. After three days of growth, the
transformed colonies were tested for prion loss (Figure 4).
Although prion curing is accomplished with varying efficiency
for each mutant, they are all sensitive to Hsp104 overexpression
despite their lack of oligopeptide repeats. Clearly, the primary
sequence of the ORD is not responsible for the sensitivity of [PSI
+]
aggregates to Hsp104 overexpression.
Replacing the ORD with a scrambled Sup35 nucleation
domain
Although the last 3K repeats of the Sup35 ORD are required
for efficient prion maintenance, they are not required for prion
nucleation or for molecular compatibility with wild-type Sup35
prion aggregates ([10]; Figure 3). Therefore, this region provides
the perfect system for examining the specific sequence/composi-
tion requirements for prion maintenance.
To determine whether specific compositional elements within
the ORD are critical for prion maintenance, we asked whether the
nucleation domain could substitute for the ORD in promoting
maintenance. We replaced the last 3K repeats of the ORD with a
scrambled version of the Sup35 PFD nucleation domain (see
supplemental information for sequences). Interestingly, none of the
resulting mutant proteins (ScrNuc1, 2 and 3) were capable of
efficiently maintaining [PSI
+]. When plasmid shuffling was used to
replace wild-type Sup35 in a [PSI
+] strain, the majority of colonies
showed significant sectoring, indicating high rates of [PSI
+] loss
(Figure 5A). In each case a small fraction of the colonies were fully
red, indicating prion loss, and a small fraction were white. When
the red colonies were re-streaked for single colonies, all of the
resulting colonies were red; by contrast, when the white colonies
were re-streaked, again mostly sectored colonies were observed
(Figure 5B). Even after multiple rounds of selecting rare white
colonies and re-streaking, no stable white colonies were ever
identified (data not shown). Thus, the ScrNuc constructs are
clearly unable to efficiently propagate wild-type [PSI
+].
This failure to propagate wild-type [PSI
+] could reflect a general
inability of the mutants to propagate prions, or it could simply
reflect an inability to propagate the specific prion variant initially
present in the yeast strain. We repeated the plasmid shuffling assay
in strains containing a number of independently derived weak and
strong prion variants; in all cases, the ScrNuc constructs were
unable to propagate the prions (data not shown). Additionally,
when cells expressing ScrNuc1, 2 or 3 were plated onto SC-ade
medium to select for spontaneous prion formation, very few Ade
+
colonies were formed with or without prion domain overexpres-
sion, even after ten days of incubation (Figure 5C); none of the
Ade
+ colonies tested for any of the three mutants were both stably
Ade
+ and guanidine HCl-curable (data not shown). Thus, the
ScrNuc mutants are not able to propagate wild-type [PSI
+]
aggregates, and do not form their own stably propagating
aggregates de novo at a detectable frequency. This demonstrates
that the composition of the ORD is critical for its ability to support
[PSI
+] propagation. However, the PFDs from the ScrNuc mutants
were able to induce wild-type [PSI
+] when overexpressed in cells
expressing full-length wild-type Sup35 (Figure 5D). This suggests
that these mutants maintain the ability to form aggregates, but are
simply unable to stably propagate these aggregates.
Figure 3. Scrambling the ORD does not prevent prion
maintenance. (A) Maintenance of [PSI
+]b ySUP35 mutants in which
the primary sequence the entire ORD or the last 3K repeats of the ORD
was scrambled. Plasmids expressing mutant versions of SUP35 were
introduce into a wild-type [PSI
+] strain by plasmid shuffling. After
testing for prion maintenance on YPD, individual white colonies were
streaked onto YPD or YPD plus 4 mM guanidine HCl and then spotted
onto YPD to test for [PSI
+]. Because no white colonies were observed for
ScrORD-2 and -3 after counterselection, pink colonies were tested. (B)
Scrambled ORD Sup35 mutants tested for de novo prion formation with
(induced) and without (uninduced) overexpression of the matching NM
domain. (C) Ade
+ colonies induced by overexpression of ScrORD-2 and




Table 2. Composition of residues 40–114 in each of the FP constructs.
Ala Arg Asn Asp Cys Gln Glu Gly His Ile Leu Lys Met Phe Pro Ser Thr Trp Tyr Val Polar
a
FP-21N 4.0 1.3 18.7 2.7 0.0 26.7 0.0 18.7 0.0 0.0 0.0 1.3 0.0 2.7 2.7 4.0 0.0 0.0 17.3 0.0 49.3
FP-21C 5.3 1.3 18.7 0.0 0.0 25.3 0.0 18.7 0.0 0.0 1.3 1.3 0.0 1.3 6.7 1.3 0.0 0.0 18.7 0.0 45.3
FP-24N 4.0 2.7 20.0 1.3 0.0 28.0 0.0 13.3 0.0 0.0 0.0 1.3 0.0 2.7 4.0 4.0 0.0 0.0 18.7 0.0 52.0
FP-24C 5.3 0.0 13.3 2.7 0.0 32.0 0.0 18.7 0.0 0.0 1.3 1.3 0.0 2.7 2.7 2.7 0.0 0.0 17.3 0.0 48.0
FP-26N 2.7 2.7 16.0 0.0 0.0 32.0 0.0 13.3 0.0 0.0 1.3 0.0 0.0 1.3 5.3 2.7 0.0 0.0 22.7 0.0 50.7
FP-26C 5.3 1.3 18.7 2.7 0.0 25.3 0.0 18.7 0.0 0.0 0.0 1.3 0.0 2.7 4.0 2.7 0.0 0.0 17.3 0.0 46.7
FP-27N 2.7 2.7 16.0 1.3 0.0 30.7 0.0 16.0 0.0 0.0 0.0 1.3 0.0 1.3 4.0 5.3 0.0 0.0 18.7 0.0 52.0
FP-27C 6.7 2.7 18.7 1.3 0.0 28.0 0.0 17.3 0.0 0.0 1.3 0.0 0.0 1.3 6.7 1.3 0.0 0.0 14.7 0.0 48.0
Shown are the compositions for the 75 amino acid sequences used to replace the ORD (residues 40–114) in each of the FP constructs.
aPolar amino acids are Asn, Gln, His, Ser, and Thr.
doi:10.1371/journal.pone.0021953.t002
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Mutagenesis analysis suggests that amyloid formation by Q/N-
rich proteins is driven by fundamentally different sequence
features than amyloid formation by non-Q/N-rich proteins.
Amyloid formation by non-Q/N-rich proteins is thought to be
driven predominantly by short, highly amyloidogenic segments
[43] while amyloid formation by Q/N-rich proteins seems to be
driven by the sum of many weaker interactions across a large,
intrinsically disordered domain [24,44]. Amyloid formation by
non-Q/N-rich proteins also appears to be more primary sequence
dependent; unlike scrambling of the Q/N-rich proteins Sup35 and
Ure2, scrambling of various non-Q/N-rich amyloid proteins
seems to block amyloid formation [45,46]. PrP is not Q/N rich,
which raises the question: Is the prion-promoting activity of the
PrP repeats primary sequence independent?
To address this question, we generated three constructs (ScrPrP-
1, 2 and 3) in which the last 3K repeats of Sup35 were replaced
with a scrambled version of the human PrP ORD (see
supplemental information for sequences). Two of the three
constructs were capable of maintaining [PSI
+] with no molecular
incompatibility (Figure 6A and data not shown). ScrPrP-3 was
incompatible with the wild-type [PSI
+] prion, but was able to form
prions de novo (Figure 6B), demonstrating that sequences in the
final 3K repeats can, under rare circumstances, create a species
barrier. Once formed, these prions were maintained efficiently in
an Hsp104-dependent manner, with no detectable prion loss
(Figure 6C and data not shown). Therefore, the ability of the PrP
repeats to substitute for the Sup35 repeats in promoting [PSI
+]
propagation is not dependent on the primary sequence of the
repeats.
Discussion
A large body of literature highlights the importance of the
Sup35 ORD for [PSI
+] maintenance [10,11,12,13,15,29,30]. The
presence of repeat elements in many other prion proteins,
including Prp, Mca1, New1 and Rnq1 seems to support the
importance of repeats. However, other yeast prion-forming
proteins such as Ure2 are capable of forming and propagating
prions without oligopeptide repeats, and scrambling the Sup35
PFD does not block [PSI
+] formation or propagation [22]. We
sought to address this disconnect.
Our experiments clearly show that the ORD is important not
for its primary sequence. While this result might be expected due
to Sup35’s insensitivity to scrambling, it remained possible that the
repeats either were required to propagate wild-type [PSI
+] [13] or
explained some unique characteristic of [PSI
+] such as sensitivity
to Hsp104 overexpression. Our results show neither of these to be
true. While deletion of even a single repeat significantly reduces
[PSI
+] mitotic stability [13], scrambling all of the repeats did not
consistently reduce the efficiency of prion formation, propagation
or sensitivity to Hsp104 overexpression. Therefore, although there
are subtle differences in prion formation and Hsp104 sensitivity
among our ScrORD mutants (and there may be other subtle
differences that we have not detected), clearly the activity of the
ORD is largely primary sequence independent.
However, the inability of the ScrNuc constructs to propagate
prions demonstrates that the distinct composition of the ORD
(relative to the nucleation domain) is critical to its functions. This
result was surprising for two reasons. First, the fact that eight
fragments tested from the scrambled versions of Sup35 were able
to support prion propagation seemed to suggest that the sequence
requirements for the ORD region were highly flexible. Second,
additional repeats can substitute for the nucleation domain in
supporting prion formation [29], which would seem to suggest that
the two domains are interchangeable; instead, the fact that the
reverse is not true argues that the compositional requirements for
nucleation are more flexible than for propagation.
Although the composition of the ORD appears to be critical for
its ability to support [PSI
+] propagation, it is unclear what aspects
of composition are important. Other studies have looked at the
overall compositional requirements for yeast prions [24,44].
However, these studies did not separately look at the composi-
tional requirements for formation versus propagation. Therefore,
defining the distinct compositional requirements for these two
activities will be important. Alexandrov et al. previously proposed
that tyrosine residues may specifically promote fiber fragmentation
[47]; however, the ScrNuc constructs have nearly identical
tyrosine content to wild-type Sup35, with twenty tyrosines in
wild-type Sup35 PFD versus nineteen in ScrNuc PFDs. By
contrast, the nucleation domain does have considerably more
polar residues and fewer glycine and proline residues than either
the PrP or Sup35 ORDs (Table 1), raising the possibility that some
combination of these compositional features could be important
for prion propagation. Intriguingly, FP24N, the only fusion
protein from Figure 2 that shows a significant propagation defect,
is tied for both the fewest glycines and most polar residues of the
eight fusion proteins (Table 2).
In scrambling the primary sequence of the ORD, we found that
repeats 1 and 2 are important determinants for molecular
compatibility between the wild-type prion and the mutant
proteins, while repeats 3 through 5K have only a weak affect
on molecular compatibility. This observation is consistent with in
vitro data that suggest repeats 1 and 2 are within the core of the
Figure 4. Hsp104 overexpression cures Sup35 ORD mutants. [PSI
+] strains expressing scrambled versions of SUP35, scrambled ORD mutants
or wild-type SUP35 were transformed either with a plasmid expressing HSP104 from the ADH1 promoter (+) or an empty vector. After 3 days growth,
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being important to fiber formation [11]. However, the primary
sequence of these repeats is not critical to the integrity of the fiber;
once mutants with repeats 1 and 2 disrupted overcame the
molecular incompatibility with wild-type [PSI
+], the prion was
propagated in a manner indistinguishable from wild-type.
Additionally, even for the first two repeats, the primary sequence
is not absolutely required for molecular compatibility with wild-
type. Two constructs in which we disrupted the first two repeats
(FP-21N and ScrORD-1) showed full molecular compatibility with
wild-type [PSI
+]. There is not a single residue in the first two
repeats of Sup35 that is conserved in both FP21N and ScrORD-1,
nor does any portion contain obvious sequence similarity, clearly
demonstrating the lack of stringent primary sequence require-
ments. Interestingly, there is also no obvious compositional feature
within this region that separates FP21N and ScrORD-1 from the
other FP and ScrORD constructs. Thus, it is possible that this
region must just be structurally compatible with wild-type [PSI
+]t o
mediate molecular compatibility, rather than requiring specific
sequence features.
Although our results appear to conflict with the wide body of
literature supporting the importance of the ORD, this difference
may be due to differences in the methods employed; past
experiments concluding the ORD is important to [PSI
+]
propagation were largely based on examination of Sup35 mutants
containing either truncated or expanded ORDs. The problem
with such studies is that in addition to changing the number of
repeats, truncating or expanding the ORD also changes the total
length of the PFD, as well as the spacing between the nucleation
domain and the Sup35 C-terminus, making it easy to misinterpret
the basis for the observed effects.
Examining the compositional requirements for the ORD may
provide insight into the basis for Hsp104 recognition of prion
aggregates. Although it has long been known that [PSI
+]i s
uniquely sensitive to Hsp104 overexpression, the basis for this
effect is unknown [48]. Hsp104 has been proposed as a tool to
combat amyloid-based neurodegenerative disorders [49]; there-
fore, determining why some amyloids are completely eliminated
by high levels of Hsp104 is important. The simplest explanation is
that differences in sensitivity to Hsp104 overexpression are due to
differences in the physical properties (such as fiber stability or
growth rate) of the aggregates formed by different proteins.
However, the scrambled versions of Sup35 have significantly
different efficiencies of prion formation and propagation, yet all
are cured by Hsp104 overexpression. This suggests that the
sequence features that allow for [PSI
+] curing by overexpression
are distinct from those that determine rates of prion formation and
strength of the prion phenotype.
While our results clearly show that the composition of the ORD
is critical for [PSI
+] propagation, questions remain regarding the
molecular basis for this activity. Based on the variety of evidence
suggesting that the ORD promotes Hsp104-dependent aggregate
cleavage [10,12,13], it was proposed that the repeats may facilitate
[PSI
+] propagation by acting as an Hsp104 binding site [10,13].
Alternatively, the ORD could affect the conformation of the fibril,
improving access of Hsp104 to the fibril core [10,13]. Our results
do not fully distinguish between these hypotheses. While our
results demonstrate that the repeats do not act as a primary-
sequence-specific Hsp104 binding site, it remains possible that
compositional elements within the repeats allow for Hsp104
binding; given that Hsp104 can recognize prion proteins with
diverse sequences, it would not be surprising for its binding to be
primary sequence independent. Alternatively, just as the Sis1
binding site within Rnq1 is outside of the PFD [34], Hsp104 may
bind outside the Sup35 PFD, with the composition of the ORD
Figure 5. ScrNuc mutants do not support [PSI
+] propagation.
(A) Molecular incompatibility between wild-type [PSI
+] aggregates and
SUP35 mutants in which the last 3K repeats of the ORD was replaced
with a scrambled Sup35 nucleation domain. Fusion proteins were
introduced into a wild-type [PSI
+] strain by plasmid shuffling and then
plated for single colonies on YPD to test for [PSI
+] by color phenotype.
(B) White and red colonies from a strain expressing ScrNuc3 were
restreaked onto YPD to test for stability of the red or white phenotype.
(C) ScrNuc mutants fail to form Ade
+ colonies de novo. ScrNuc mutants
were tested for de novo prion formation with (2) and without (+)
overexpression of the matching NM domain. To allow for detection of
slow-growing Ade
+ colonies, plates were grown for ten days instead of
the standard six days. (D) Overexpression of the ScrNuc PFDs induces
wild-type [PSI
+] formation. Yeast expressing full-length wild-type Sup35
were transformed with an empty vector (uninduced), or with a plasmid
overexpressing either wild-type Sup35 (wild-type) or one of the ScrNuc
(ScrNuc-1, -2 and -3) PFDs. Cells were grown in galactose/raffinose
dropout medium and serial dilutions plated onto medium lacking
adenine to select for [PSI
+].
doi:10.1371/journal.pone.0021953.g005
Figure 6. ScrPrP mutants maintain wild type [PSI
+]. (A)
Maintenance of [PSI
+] by fusion proteins in which the last 3K repeats
of the ORD was replaced with scrambled PrP ORDs. (B) De novo prion
formation for ScrPrP-3, with (induced) and without (uninduced)
overexpression of the matching PFD. (C) Curability of the Ade
+
phenotype in the scrambled PrP mutants.
doi:10.1371/journal.pone.0021953.g006
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fiber core.
If primary sequence has little effect on prion formation and
propagation, why are repeats found in several prion-forming
proteins? Analysis of the sequence requirements for prion
formation suggests that yeast prion domains are characterized by
long disordered regions of modest prion propensity, rather than
short regions of high prion propensity [24]. Repeat expansion
provides a simple mechanism for generating such regions. The
simplest way to generate a long disordered region of modest prion
propensity would be to duplicate a short disordered region of
modest prion propensity. Thus, we propose that repeats are found
in many yeast prion domains not because repeat sequences affect
the biochemistry of prion formation or propagation, but instead
because they provide a genetic mechanism for domain expansion,
and therefore prion domain generation.
Prior to this work, we viewed the ability of the PrP ORD to
substitute for the Sup35 ORD with some skepticism; it seemed
possible that the Sup35 ORD might simply act as a relatively non-
specific spacer, promoting prion propagation by separating the
nucleation domain from the charged M domain. If, for example,
any relatively uncharged segment could serve this function, the
ability of the PrP repeats to substitute for the Sup35 repeats would
not be particularly meaningful, and might not reveal anything
about the function of the repeats within PrP. However, our
observation that compositional changes in the ORD region can
block prion propagation makes the ability of the PrP repeats to
substitute for the Sup35 ORD more meaningful, and furthers the
connection between Sup35 and PrP repeats. Additionally, the
primary sequence insensitivity of the PrP ORD is noteworthy, as
this is, to our knowledge, the first example of a non-Q/N-rich
amyloid-promoting domain showing primary-sequence indepen-
dence. It remains possible that the primary sequence of the ORD
has some prion-promoting function within the context of PrP.
However, these results raise the possibility that the disease-
promoting effects of PrP ORD expansions [50,51] may not be due
to the actual repeats per se, but due to the fact that expansion of a




Standard yeast media and methods were used as previously
described [52], except the YPD contained 0.5% yeast extract
instead of the standard 1%. In all experiments, yeast were grown
at 30uC. All experiments were performed in Saccharomyces cerevisiae
strain 780-1D/pJ533 [53]. This strain’s genotype is a kar1-1 SWQ5
ade2-1 his3 leu2 trp1 ura3 sup35::KanMx [PSI
+] [PIN
+]; pJ533
expresses SUP35 from a URA3 plasmid as the sole copy of SUP35
in the cell.
Replacing the Sup35 ORD
FP21C, FP24C, FP26C, and FP27C were constructed in two
steps. Fragments from the scrambled Sup35s were amplified by
PCR using primer EDR262 paired with a construct-specific
primer (see Supplemental Table S1 for all oligonucleotide
sequences). The N-terminal portion of the PFD was amplified in
a separate reaction from pJ533 using primers EDR257 and
EDR313. N-terminal and scrambled fragments were combined
and reamplified with EDR259 and EDR261. PCR products were
co-transformed with AatII/HindIII-cut pJ526 (from Dan Masison,
National Institutes of Health) into yeast strain 780-1D/pJ533.
Transformants were selected on SC-leu and then stamped onto 5-
fluoroorotic acid (5-FOA) containing medium to select for loss of
pJ533. Plasmids expressing mutant SUP35s were confirmed by
DNA sequencing.
FP21N, FP24N, FP26N, and FP27N were assembled from three
pieces. In separate reactions, the N-terminal portion of the prion
domain and the M domain were amplified from pJ533 using
primer pairs EDR257/313 and EDR322/262, respectively.
Fragments from the scrambled Sup35s were amplified by PCR
using construct-specific primers; these products were combined
with the N-terminal and M-domain PCR products, re-amplified
with EDR259 and EDR261, and cloned into pJ526.
The scrambled portion of the ScrORD constructs was built
using six overlapping oligonucleotides (EDR896, EDR236,
EDR243, and three construct-specific oligonucleotides). In a
separate reaction, the N-terminal portion of the PFD was
amplified from pJ533 using primers EDR348 and EDR897. The
N-terminal and ORD fragments were combined, re-amplified with
EDR869 and EDR871, and cloned into pJ526.
For each of the ScrPrP and ScrKORD constructs except for
ScrPrP2, the scrambled portion of the prion domain was built
using four overlapping oligonucleotides (EDR896, EDR236 and
two construct-specific oligonucleotides). In a separate reaction, the
N-terminal portion of the PFD was amplified from pJ533 using
primers EDR348 and EDR870. The N-terminal and ORD
fragments were combined, re-amplified with EDR348 and
EDR243, and cloned into pJ526. ScrPrP2 was built like the
ScrORD constructs, using six overlapping oligonucleotides
(EDR947, 948, 893, 896, 236, and 243) to assemble the scrambled
portion.
The ScrNuc constructs were assembled from separate N- and
C-terminal PCR reactions. The N-terminal portion was amplified
from pJ533 using EDR257, paired with EDR1025, 1030 or 1034,
respectively. The C-terminal portion of ScrNuc2 was amplified
from pJ533 using EDR305 paired with EDR1031. The C-terminal
portions of ScrNuc-1 and -3 were generated in two steps. First,
EDR305 and EDR1027 were used to PCR amplify from pJ533;
this product was then re-amplified with EDR262, paired with
either EDR1026 or EDR1035. For each ScrNuc construct, the N-
and C-terminal fragments were combined, re-amplified with
EDR259 and EDR261, and cloned into pJ526.
Testing for prion maintenance and curing
Plasmids expressing Sup35 mutants were transformed into
strain 780-1D/pJ533. Transformed colonies were re-suspended in
water in a 96-well microtiter plate, spotted onto minimal media
plates containing 5-FOA and grown for 2–3 days at 30uC to select
for loss of pJ533. Cells from the 5-FOA plates were streaked onto
YPD plates to test for [PSI
+].
To test for curability, white Ade
+ colonies were grown on
YPAD or YPAD plus 4 mM guanidine HCl (GdHCl). Single
colonies were spotted onto YPD to test for loss of [PSI
+].
Induction experiments
To generate induction plasmids, the N and M domains of the
mutant SUP35s were amplified by PCR with primers EDR1008
and EDR969, installing a BamHI site before the start codon, and a
stop codon and PstI site after the M domain. PCR products were
digested with BamHI and PstI and inserted into BamHI/PstI-cut
pKT24 (from Kim Taylor, NABI, Rockville, MD), which contains
the GAL1 promoter [54]. Ligation products were transformed into
Escherichia coli and analyzed by DNA sequencing. Induction
experiments were performed as previously described [54]. The
wild-type induction plasmid, pER161, was previously described
[PSI
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inductions, which were grown for ten.
Prion curing by Hsp104 over-expression
Strains were transformed with pER10, which expresses HSP104
from the ADH1 promoter or a vector control (pER41).
Transformed colonies were re-suspended in water in a 96-well
microtiter plate, spotted onto YPD to test for loss of [PSI
+].
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